Basic and Diluted Net Income (Loss) per Share (Tables)

3 Months Ended

Mar. 31, 2022

Earnings Per Share [Abstract]

Summary of Net Income (loss) Per Share

The following table presents information necessary to calculate net income (loss) per share:

	Three Months Ended March 31,
	2022		2021
Numerator:
Net income (loss) attributable to Thorne HealthTech, Inc.	$	4,979,059	$	4,706,490
Undistributed earnings attributable to Series E convertible preferred stockholders	N/A			(4,706,490	)
Numerator for basic EPS—net income (loss) available to Thorne HealthTech, Inc. common stockholders (A)		4,979,059		—
Effect of dilutive securities:
Undistributed earnings attributable to Series E convertible preferred stockholders—basic	N/A			4,706,490
Undistributed earnings attributable to Series E convertible preferred stockholders—diluted	N/A			(4,706,490	)
		—		—
Numerator for diluted EPS—net income (loss) available to Thorne HealthTech, Inc. common stockholders (C)		4,979,059		—
Denominator:
Denominator for basic EPS—weighted average shares (B)		52,564,779		17,650,035
Effect of dilutive securities(1):
Stock options		60,172		—
RSUs		—		—
Warrants		—		—
Dilutive potential common shares		60,172		—
Denominator for diluted EPS—adjusted weighted average common stock and common stock equivalents (D)		52,624,951		17,650,035
Basic EPS (A/B)	$	0.09	$	—
Diluted EPS (C/D)	$	0.09	$	—

(1)Approximately 16.1 million warrants and stock-based awards were excluded from the computation of diluted EPS for the three months ended March 31, 2022, because the effect would have been anti-dilutive under the treasury stock method.